COVID-19, shock séptico refractario y terapia extracorpórea de purificación sanguínea con OXIRIS® / Management of refractory septic shock with blood purification therapy using a special filter: report of one case
Rev. méd. Chile
;
150(2): 266-270, feb. 2022. ilus, tab
Artículo
en Español
| LILACS
| ID: biblio-1389636
ABSTRACT
Sepsis is one of the leading causes of death in critically ill patients with COVID-19 and blood purification therapies have a role to immunomodulate the excessive inflammatory response and improve clinical results. One of the devices designed for these therapies is the oXiris® filter, allowing to perform renal replacement therapy combined with selective adsorption of endotoxins and cytokines. We report a 55-year-old male with COVID who developed a septic shock secondary to a sepsis caused by Pseudomona aeruginosa, refractory to the usual management. A veno-venous continuous hemofiltration was started using the oXiris® filter for 48 hours. Subsequently, there was an improvement in clinical perfusion parameters and a reduction in inflammatory markers. The patient was discharged from the intensive care one month later.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Choque Séptico
/
Sepsis
/
COVID-19
Límite:
Humanos
/
Masculino
Idioma:
Español
Revista:
Rev. méd. Chile
Asunto de la revista:
Medicina
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Chile
Institución/País de afiliación:
Hospital Carlos Van Buren/CL
Similares
MEDLINE
...
LILACS
LIS